Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles K Cooper

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 10, 2021
Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ systemSonia Paradis, Elizabeth Lockamy, Charles K Cooper, et al.
Microbiology Spectrum|April 12, 2022
Clinical Evaluation of BD Veritor SARS-CoV-2 and Flu A+B Assay for Point-Of-Care SystemKatherine Christensen, Huimiao Ren, Shirley Chen, et al.
Journal of Biopharmaceutical Statistics|June 1, 2022
A pragmatic approach for dynamically incorporating predicate device data in prospective diagnostic test studiesGraeme L Hickey, Valentin Parvu, Yongqiang Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2018
Molecular-based Testing for Sexually Transmitted Infections Using Samples Previously Collected for Vaginitis DiagnosisBarbara Van Der Pol, Grace Daniel, Salma Kodsi, et al.
Frontiers in Public Health|April 22, 2022
Large-Scale SARS-CoV-2 Antigen Testing With Real-World SpecimensAshish Parikh, Lauren Cooper, Daniel Frogel, et al.
Gynecologic Oncology|January 15, 2019
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytologyMark H Stoler, Thomas C Wright, Valentin Parvu, et al.
Journal of Clinical Microbiology|April 13, 2018
Diagnostic Performance of a Molecular Test versus Clinician Assessment of VaginitisJane R Schwebke, Charlotte A Gaydos, Paul Nyirjesy, et al.
Gynecologic Oncology|January 22, 2023
Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trialMark H Stoler, Thomas C Wright, Valentin Parvu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 23, 2024
Emergency department clinical performance of ADVIA Centaur n-terminal prohormone of B-type natriuretic peptide assayW Frank Peacock, Jennifer Snyder, Chadwick Brown, et al.
Gynecologic Oncology|March 12, 2019
HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: Results from the baseline phase of the Onclarity trialThomas C Wright, Valentin Parvu, Mark H Stoler, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 10, 2021
Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ systemSonia Paradis, Elizabeth Lockamy, Charles K Cooper, et al.
Microbiology Spectrum|April 12, 2022
Clinical Evaluation of BD Veritor SARS-CoV-2 and Flu A+B Assay for Point-Of-Care SystemKatherine Christensen, Huimiao Ren, Shirley Chen, et al.
Journal of Biopharmaceutical Statistics|June 1, 2022
A pragmatic approach for dynamically incorporating predicate device data in prospective diagnostic test studiesGraeme L Hickey, Valentin Parvu, Yongqiang Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2018
Molecular-based Testing for Sexually Transmitted Infections Using Samples Previously Collected for Vaginitis DiagnosisBarbara Van Der Pol, Grace Daniel, Salma Kodsi, et al.
Frontiers in Public Health|April 22, 2022
Large-Scale SARS-CoV-2 Antigen Testing With Real-World SpecimensAshish Parikh, Lauren Cooper, Daniel Frogel, et al.
Gynecologic Oncology|January 15, 2019
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytologyMark H Stoler, Thomas C Wright, Valentin Parvu, et al.
Journal of Clinical Microbiology|April 13, 2018
Diagnostic Performance of a Molecular Test versus Clinician Assessment of VaginitisJane R Schwebke, Charlotte A Gaydos, Paul Nyirjesy, et al.
Gynecologic Oncology|January 22, 2023
Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trialMark H Stoler, Thomas C Wright, Valentin Parvu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 23, 2024
Emergency department clinical performance of ADVIA Centaur n-terminal prohormone of B-type natriuretic peptide assayW Frank Peacock, Jennifer Snyder, Chadwick Brown, et al.
Gynecologic Oncology|March 12, 2019
HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: Results from the baseline phase of the Onclarity trialThomas C Wright, Valentin Parvu, Mark H Stoler, et al.
Pageof 3